NEOG

NEOGEN CORP NEOG

NasdaqMid CapHealthcare

13F Pro quality score

Rank #2,042 of 2,925

Why it scores 42Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$222.80M

Quarter to Aug 31

Net income

$-11.90M

Quarter to Aug 31

Free cash flow

$4.70M

Quarter to Aug 31

Operating margin

-0.8%

Quarter to Aug 31

Top Institutional Holders

as of Q2 2026
$2.13B total
BlackRock, Inc.
$300.54M+2.5%
Neuberger Berman Group LLC
$149.00M+113.8%
VANGUARD PORTFOLIO MANAGEMENT LLC
$117.22M+1.6%
DIMENSIONAL FUND ADVISORS LP
$88.36M+7.6%
VANGUARD CAPITAL MANAGEMENT LLC
$86.80M+0.9%
SG Americas Securities, LLC
$84.08M+49.3%
T. Rowe Price Investment Management, Inc.
$83.91M-8.2%
ING GROEP NV
$81.83M+2.2%
STATE STREET CORP
$80.43M+4.1%
Gates Capital Management, Inc.
$78.59M+39.7%
Hudson Bay Capital Management LP
$58.44M0.0%
GEODE CAPITAL MANAGEMENT, LLC
$52.45M+4.9%
BAMCO INC /NY/
$45.09M+0.1%
MORGAN STANLEY
$38.71M-6.0%
MIZUHO MARKETS AMERICAS LLC
$38.21M+21.4%
NATIONAL BANK OF CANADA /FI/
$35.96M+14.3%
CIBC Bancorp USA Inc.
$31.91M-40.8%
CIBC WORLD MARKET INC.
$31.47M-41.3%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
$31.36M+5.8%
MUFG Securities EMEA plc
$29.85M-17.0%
SG Capital Management LLC
$29.84M+55.3%
AMERIPRISE FINANCIAL INC
$29.35M+46.9%
BANK OF AMERICA CORP /DE/
$28.28M-32.2%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$26.97M-1.8%
NOMURA HOLDINGS INC
$25.05M+33.4%
See all 317 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q1 2027
EDGAR

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

Operating Margin

Q1 2027
EDGAR

ROIC

Q1 2027
EDGAR

Free Cash Flow

Q1 2027
EDGAR

Debt/Equity

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NEOG

Earnings Per Share

13fpro.ai/company/NEOG

Loading ratio trend…

NEOG key financials by period

Reported revenue, net income and operating margin by fiscal year, from NEOGEN CORP's annual filings on SEC EDGAR.

NEOGEN CORP reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2026$870.4M$-7.9M-2.5%
FY 2025$894.7M$-1.1B-118.6%
FY 2024$924.2M$-9.4M6.3%
FY 2023$822.4M$-22.9M4.6%
FY 2022$527.2M$48.3M11.1%
FY 2021$468.5M$60.9M15.8%
Source: NEOG filings on SEC EDGAR →

Companies similar to NEOG

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

NEOG insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About NEOGEN CORP (NEOG): stock profile, AI score and financials

NEOGEN CORP (NEOG) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NEOG at 41.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,042 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (20.2) and balance sheet strength (29.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 44.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2027), NEOGEN CORP reports quarterly revenue of $222.8M, net income of $-11.9M, an operating margin of -0.8%. NEOG trades on the Nasdaq exchange and files with the SEC under CIK 711377. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NEOG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NEOGEN CORP directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 711377 →